title: Total body irradiation after high-dose cytarabine in mantle cell lymphoma: a comparison of Nordic MCL2, HOVON-45, and European MCL Younger trials.
authors.affiliation: Department of Internal Medicine III, University Hospital Munich, Munich, Germany.|Institute of Medical Informatics, Biometry, and Epidemiology, University of Munich, Munich, Germany.
authors.forename: E
authors.initials: E
authors.lastname: Hoster
authors.affiliation: Hematology Department, Rigshospitalet, Copenhagen, Denmark.
authors.forename: C H
authors.initials: CH
authors.lastname: Geisler
authors.affiliation: Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
authors.forename: J
authors.initials: J
authors.lastname: Doorduijn
authors.affiliation: HOVON Data Center, Erasmus MC Cancer Institute - Clinical Trial Center, Rotterdam, The Netherlands.
authors.forename: B
authors.initials: B
authors.lastname: van der Holt
authors.affiliation: Department of Lymphoid Malignancies, The Maria Skłodowska-Curie Memorial Institute and Oncology Center, Warsaw, Poland.
authors.forename: J
authors.initials: J
authors.lastname: Walewski
authors.affiliation: Department of Internal Medicine III, University of Ulm, Ulm, Germany.
authors.forename: J
authors.initials: J
authors.lastname: Bloehdorn
authors.affiliation: Institut Gustave Roussy, Villejuif, France.
authors.forename: V
authors.initials: V
authors.lastname: Ribrag
authors.affiliation: Hospices Civils de Lyon, Université Claude Bernard, Pierre Bénite, France.
authors.forename: G
authors.initials: G
authors.lastname: Salles
authors.affiliation: Department I of Internal Medicine, University of Cologne, Cologne, Germany.
authors.forename: M
authors.initials: M
authors.lastname: Hallek
authors.affiliation: Second Medical Department, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.
authors.forename: C
authors.initials: C
authors.lastname: Pott
authors.affiliation: Department of Lymphoid Malignancies, The Maria Skłodowska-Curie Memorial Institute and Oncology Center, Warsaw, Poland.
authors.forename: M
authors.initials: M
authors.lastname: Szymczyk
authors.affiliation: Oncology Department, The Norwegian Radium Hospital, Oslo, Norway.
authors.forename: A
authors.initials: A
authors.lastname: Kolstad
authors.affiliation: Department of Oncology, Uppsala University Hospital, Uppsala, Sweden.
authors.forename: A
authors.initials: A
authors.lastname: Laurell
authors.affiliation: Department of Hematology, Helsinki University Central Hospital, Helsinki, Finland.
authors.forename: R
authors.initials: R
authors.lastname: Räty
authors.affiliation: Department of Oncology, Skane University Hospital, Lund, Sweden.
authors.forename: M
authors.initials: M
authors.lastname: Jerkeman
authors.affiliation: Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
authors.forename: M
authors.initials: M
authors.lastname: Van't Veer
authors.affiliation: Department of Hematology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
authors.forename: J C
authors.initials: JC
authors.lastname: Kluin-Nelemans
authors.affiliation: Department of Pathology, Hematopathology Section and Lymph Node Registry, University of Kiel, Kiel, Germany.
authors.forename: W
authors.initials: W
authors.lastname: Klapper
authors.affiliation: Department of Internal Medicine III, University Hospital Munich, Munich, Germany.
authors.forename: M
authors.initials: M
authors.lastname: Unterhalt
authors.affiliation: Department of Internal Medicine III, University Hospital Munich, Munich, Germany.
authors.forename: M
authors.initials: M
authors.lastname: Dreyling
authors.affiliation: Department of Hematology, Hôpital Necker, Assistance Publique Hôpitaux de Paris, University Paris Descartes, Paris, France.|INSERM U1163 and CNRS 8254, Imagine Institute, Université Sorbonne Paris Cité, Paris, France.
authors.forename: O
authors.initials: O
authors.lastname: Hermine
mesh_terms: D000328:Adult; D000368:Aged; D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage / Q000627:therapeutic use*; D059248:Chemoradiotherapy; D003561:Cytarabine / Q000008:administration & dosage / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D006801:Humans; D020522:Lymphoma, Mantle-Cell / Q000628:therapy*; D008875:Middle Aged; D033581:Stem Cell Transplantation; D014916:Whole-Body Irradiation
chemical_list: D000964:Antimetabolites, Antineoplastic; D003561:Cytarabine